Lumentum vs Medline Inc. Class A Common Stock — how do they compare? Lumentum trades at $1,104.3 (market cap $94.99B), while Medline Inc. Class A Common Stock trades at $36.14 (market cap $31.36B). The key difference: Lumentum is far larger — about 3× Medline Inc. Class A Common Stock's market cap, and Medline Inc. Class A Common Stock is more actively traded (10,191,251 versus 4,855,776). Which is the better fit depends on your goals — on Pluang, investors hold Lumentum for 4 Days and Medline Inc. Class A Common Stock for 1 Days on average.
| LITE | MDLN | |
|---|---|---|
Market Cap | $94.99B | $31.36B |
Volume | 4,855,776 | 10,191,251 |
Sector | Technology | Health |
52-Week High | $1.13K | $49.99 |
52-Week Low | $149.61 | $31.64 |
Typical Hold Time | 4 Days | 1 Days |
Enterprise Value | $93.92B | $41.32B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →